GR3025488T3 - Transformed erythrocytes, process for preparing the same, and their use in pharmaceutical compositions - Google Patents

Transformed erythrocytes, process for preparing the same, and their use in pharmaceutical compositions

Info

Publication number
GR3025488T3
GR3025488T3 GR970403137T GR970403137T GR3025488T3 GR 3025488 T3 GR3025488 T3 GR 3025488T3 GR 970403137 T GR970403137 T GR 970403137T GR 970403137 T GR970403137 T GR 970403137T GR 3025488 T3 GR3025488 T3 GR 3025488T3
Authority
GR
Greece
Prior art keywords
preparing
same
pharmaceutical compositions
erythrocytes
transformed
Prior art date
Application number
GR970403137T
Other languages
English (en)
Inventor
Mauro Magnani
Luigia Rossi
Original Assignee
Europ Communities
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Europ Communities filed Critical Europ Communities
Publication of GR3025488T3 publication Critical patent/GR3025488T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5063—Compounds of unknown constitution, e.g. material from plants or animals
    • A61K9/5068—Cell membranes or bacterial membranes enclosing drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/18—Erythrocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
GR970403137T 1991-06-14 1997-11-26 Transformed erythrocytes, process for preparing the same, and their use in pharmaceutical compositions GR3025488T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91401602A EP0517986B1 (en) 1991-06-14 1991-06-14 Transformed erythrocytes, process for preparing the same, and their use in pharmaceutical compositions

Publications (1)

Publication Number Publication Date
GR3025488T3 true GR3025488T3 (en) 1998-02-27

Family

ID=8208584

Family Applications (1)

Application Number Title Priority Date Filing Date
GR970403137T GR3025488T3 (en) 1991-06-14 1997-11-26 Transformed erythrocytes, process for preparing the same, and their use in pharmaceutical compositions

Country Status (10)

Country Link
US (1) US5753221A (el)
EP (1) EP0517986B1 (el)
JP (1) JPH06510742A (el)
AT (1) ATE157879T1 (el)
CA (1) CA2102619A1 (el)
DE (1) DE69127615T2 (el)
DK (1) DK0517986T3 (el)
ES (1) ES2109260T3 (el)
GR (1) GR3025488T3 (el)
WO (1) WO1992022306A1 (el)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5409710A (en) * 1993-04-20 1995-04-25 Endocon, Inc. Foam cell drug delivery
AU688552B2 (en) * 1994-07-15 1998-03-12 Biosearch Italia S.P.A. Dinucleoside-5',5'-pyrophosphates
EP0882448B1 (en) * 1997-05-05 2005-01-12 DIDECO S.r.l. Method of encapsulating biologically active agents within erythrocytes and apparatus therefor
ES2257050T3 (es) 1998-05-26 2006-07-16 Lifecell Corporation Conservacion por el frio de hematies humanos.
US20100042072A1 (en) * 2008-08-13 2010-02-18 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Biological targeting compositions and methods of using the same
US20110092961A1 (en) * 2008-08-13 2011-04-21 Searete Llc Artificial cells
US8211656B2 (en) 2008-08-13 2012-07-03 The Invention Science Fund I, Llc Biological targeting compositions and methods of using the same
US20100040546A1 (en) * 2008-08-13 2010-02-18 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Biological targeting compositions and methods of using the same
WO2010025322A2 (en) * 2008-08-28 2010-03-04 The Florida International University Board Of Trustees Magnetic nanodelivery of therapeutic agents across the blood brain barrier
AU2014348683B2 (en) 2013-11-18 2020-11-05 Rubius Therapeutics, Inc. Synthetic membrane-receiver complexes
RU2736495C2 (ru) 2014-04-01 2020-11-17 Рубиус Терапьютикс, Инк. Способ и композиции для иммуномодуляции
EP3727434A1 (en) 2017-12-23 2020-10-28 Rubius Therapeutics, Inc. Artificial antigen presenting cells and methods of use
SG11202008261WA (en) 2018-03-08 2020-09-29 Rubius Therapeutics Inc Therapeutic cell systems and methods for treating cancer and infectious diseases
KR20220005028A (ko) 2019-04-26 2022-01-12 루비우스 테라퓨틱스, 아이엔씨. 탈핵 적혈구를 포함하는 조성물
AU2020283752A1 (en) 2019-05-24 2021-12-23 Rubius Therapeutics, Inc. Methods of generating enucleated erythroid cells
CN115038784A (zh) 2019-11-04 2022-09-09 鲁比厄斯治疗法股份有限公司 使用肌-肌醇产生去核红系细胞的方法
KR20220093196A (ko) 2019-11-04 2022-07-05 루비우스 테라퓨틱스, 아이엔씨. 타우린 또는 하이포타우린을 사용하여 제핵 적혈구 세포를 생성하는 방법
TW202241470A (zh) 2021-01-08 2022-11-01 美商盧比亞斯治療公司 治療人類個體腫瘤之方法
WO2022150569A1 (en) 2021-01-08 2022-07-14 Rubius Therapeutics, Inc. METHODS OF INCREASING NKp30-POSITIVE LYMPHOCYTES IN A SUBJECT AND USES THEREOF
TW202304482A (zh) 2021-03-14 2023-02-01 美商盧比亞斯治療公司 於個體中增加nkg2d陽性淋巴球之方法及其用途
TW202317179A (zh) 2021-06-03 2023-05-01 美商盧比亞斯治療公司 在個體中治療ｈｐｖ１６－陽性或ｈｐｖ１６－相關的癌症之方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2529463B1 (fr) * 1982-07-05 1986-01-10 Centre Nat Rech Scient Procede et dispositif pour l'encapsulation dans les erythrocytes d'au moins une substance a activite biologique, notamment des effecteurs allosteriques de l'hemoglobine et erythrocytes ainsi obtenus
IL86650A0 (en) * 1987-06-30 1988-11-30 Biophor Corp Animal derived cells and liposomes,having an antigenic protein incorporated into their membrane
FR2653561A1 (fr) * 1989-10-19 1991-04-26 Fondation Nale Transfusion San Hetero-anticorps anti-rhd et composition pharmaceutique les contenant.

Also Published As

Publication number Publication date
US5753221A (en) 1998-05-19
CA2102619A1 (en) 1992-12-15
ATE157879T1 (de) 1997-09-15
EP0517986B1 (en) 1997-09-10
DK0517986T3 (da) 1998-03-30
JPH06510742A (ja) 1994-12-01
DE69127615D1 (de) 1997-10-16
DE69127615T2 (de) 1998-03-19
ES2109260T3 (es) 1998-01-16
EP0517986A1 (en) 1992-12-16
WO1992022306A1 (en) 1992-12-23

Similar Documents

Publication Publication Date Title
GR3025488T3 (en) Transformed erythrocytes, process for preparing the same, and their use in pharmaceutical compositions
IE842979L (en) Desulfatohirudins
UA39158C2 (uk) Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
EP0509317A3 (en) Use of droloxifene in the treatment of bone diseases
EP0285008A3 (en) The use of buspirone for preparing a pharmaceutical composition for the treatment of alcohol abuse
NO902800D0 (no) Fremgangsmaate for fremstilling av 11beta-aryl-4-oestrener.
ES2160643T3 (es) Composiciones que contienen g-csf y proteina de union al tnf.
DE68929388D1 (de) Aus Harn isolierte antikoagulierende Verbindung
ZA923940B (en) Substituted diaminophthalimides and analogues
IL112074A0 (en) Branched-amino-substituted thiazoles, their preparation and pharmaceutical compositions containing them
EP0347899A3 (en) Pharmaceutical compositions on egg shell basis and their preparation and use
IL141325A0 (en) Tan-1057 derivatives
DE3887068D1 (de) 2,2-Dimethylchromenderivate, Verfahren zur Herstellung und diese enthaltende pharmazeutische Zusammenstellungen.
ES2001774A6 (es) Procedimiento para la preparacion de nuevos pirrolo-bencimidazoles, pirrolo-benzoxazoles y pirrolo-benzotiazoles.
DE68927055D1 (de) 2',5'-oligoadenylat-derivate zur verwendung als heilmittel
IL91152A0 (en) Furylthiazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
EP0487996A3 (en) Cephalosporins substituted in position 3, process for their preparation and their use as medicine
IL102815A (en) Pharmaceutical compositions for the treatment of infection caused by the human immunodeficiency virus
IL87197A0 (en) Leukotriene antagonists,precursors of same,processes for the preparation thereof and pharmaceutical compositions containing same
GR3024709T3 (en) Novel cytarabine derivatives, their production and use
ATE74767T1 (de) Arzneimittelzusammensetzung zur behandlung des lungenverstopfens.